Metabolic Reprogramming in Lung Cancer and Its Clinical Implication

publication Evidence: high

Author Information

Author(s): Huang Qingqiu, Fan Lisha, Gong Mingjing, Ren Juntong, Chen Chen, Xie Shenglong

Primary Institution: University of Electronic Science and Technology of China

The study reviews the metabolic reprogramming of lung cancer cells and its implications for treatment.

The metabolic reprogramming of lung cancer cells is a key driver of tumor development and presents potential therapeutic targets.

Lung cancer is a major global health challenge, with significant mortality rates.
Metabolic reprogramming is recognized as a hallmark of cancer.
Targeting metabolic pathways may lead to new therapeutic strategies for lung cancer.
Glucose metabolism is crucial for the proliferation of lung cancer cells.
Fatty acid metabolism is also important for tumor growth and progression.
Amino acid metabolism plays a significant role in cancer cell survival.
Research indicates that metabolic alterations can affect the tumor microenvironment.
Understanding these metabolic changes can improve treatment outcomes for lung cancer patients.

Lung cancer cells change how they use energy and nutrients to grow faster, and understanding this can help find new treatments.

The study summarizes recent research on tumor metabolism in lung cancer, focusing on metabolic products and enzymes.

The review primarily focuses on glucose, lipid, and amino acid metabolism, potentially overlooking other important metabolic pathways.

Access the complete publication on the publisher's website